Invention Grant
US08834876B2 Therapeutic agent for hematopoietic tumors 有权
造血肿瘤治疗剂

Therapeutic agent for hematopoietic tumors
Abstract:
An inducing agent or enhancing agent, for the expression of HM1.24 antigen in hematopoietic tumor cells, comprising interferon α, interferon γ, or the IRF-2 protein as an active ingredient, as well as an antitumor agent for hematopoietic tumors which comprises a combination of said inducing agent or enhancing agent and an antibody against HM1.24.
Public/Granted literature
Information query
Patent Agency Ranking
0/0